EDSA
Edesa Biotech Inc
3.50$
-4.1%
vs. previous close
Closing price · As of: Oct 9, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 70.6% | 69.2% | 65.5% | 58.3% | 43.9% | 49.8% | 87.4% | 86.2% | 84.3% | 86.5% | 84.1% | 84.7% | |
| 58.8% | 54.5% | 43.2% | 39.0% | 27.2% | 37.5% | 84.5% | 83.5% | 79.0% | 81.9% | 80.8% | 81.2% | |
| 58.8% | 54.5% | 43.2% | 39.0% | 27.2% | 37.5% | 84.5% | 83.5% | 79.0% | 81.9% | 80.8% | 81.2% | |
| 6.9% | 9.5% | 17.2% | 10.5% | 7.1% | 8.4% | 2.3% | 1.9% | 4.7% | 2.9% | 1.7% | 1.8% | |
| -11.8% | – | – | 0.0% | – | – | – | – | – | – | – | – | |
| 23.9% | 27.5% | 32.9% | 40.2% | 54.5% | 49.3% | 12.3% | 13.5% | 14.5% | 13.3% | 15.6% | 14.9% | |
| 22.7% | 25.4% | 33.2% | 45.2% | 48.1% | 45.6% | 5.6% | 4.5% | 8.9% | 5.1% | 17.7% | 30.7% | |
| 20.0% | 25.4% | 33.2% | 45.2% | 48.1% | 45.6% | 5.6% | 4.5% | 7.9% | 5.1% | 17.7% | 30.7% | |
| 0.8% | 1.0% | 0.9% | 0.7% | 0.5% | – | – | – | – | – | – | – | |
| 0.0% | 0.0% | 32.3% | 44.4% | 47.5% | 45.6% | 5.6% | 4.5% | – | 5.1% | – | – | |
| 77.3% | 74.6% | 66.8% | 54.8% | 51.9% | 54.4% | 94.4% | 95.5% | 91.1% | 94.9% | 82.3% | 69.3% | |
| -574.6% | -690.7% | -864.2% | -1,102.3% | -1,536.2% | -1,446.4% | -375.9% | -429.9% | -482.5% | -463.6% | -585.0% | -612.3% | |
| 33.2% | 39.9% | 49.3% | 61.6% | 85.2% | 80.3% | 32.2% | 47.4% | 51.6% | 54.2% | 69.0% | 70.8% |
Data as of: October 9, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.